S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Northeast Georgia Medical Center Transitions Imaging to Sectra Cloud

Northeast Georgia Medical Center has launched the Sectra One Cloud platform, centralizing radiology, breast imaging, and cardiology workflows for its regional network. This transition shifts infrastructure management to the vendor, aiming to streamline diagnostic processes for a population of 1.5 million people across 19 Georgia counties.

Northeast Georgia Medical Center Transitions Imaging to Sectra Cloud
Photo: Bio & News

The five-year agreement, finalized during the 2025/2026 fiscal year, covers an estimated annual volume of 850,000 imaging exams. By migrating to a unified cloud-based system, the health system intends to eliminate the friction caused by switching between disparate applications. Richard Wright, Executive Director of Imaging Services, noted that the platform allows clinicians across different sites and specialties to collaborate on the same case simultaneously rather than working in isolation.

Under this service model, Sectra assumes responsibility for system maintenance, continuous monitoring, and software upgrades. This approach is designed to mitigate operational risks and ensure high system availability at the Gainesville flagship facility and its four affiliated campuses. Isaac Zaworski, President of Sectra Inc., emphasized that the modular architecture allows the hospital system to scale its digital capabilities into additional specialties as clinical needs evolve.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!